| Antibody-drug conjugates for cancer therapy: chemistry to clinical implications N Dan, S Setua, VK Kashyap, S Khan, M Jaggi, MM Yallapu, SC Chauhan Pharmaceuticals 11 (2), 32, 2018 | 231 | 2018 |
| Tannic acid-inspired paclitaxel nanoparticles for enhanced anticancer effects in breast cancer cells P Chowdhury, PKB Nagesh, E Hatami, S Wagh, N Dan, MK Tripathi, ... Journal of colloid and interface science 535, 133-148, 2019 | 146 | 2019 |
| Superparamagnetic iron oxide nanoparticles of curcumin enhance gemcitabine therapeutic response in pancreatic cancer S Khan, S Setua, S Kumari, N Dan, A Massey, BB Hafeez, MM Yallapu, ... Biomaterials 208, 83-97, 2019 | 134 | 2019 |
| Tannic acid inhibits lipid metabolism and induce ROS in prostate cancer cells PKB Nagesh, P Chowdhury, E Hatami, S Jain, N Dan, VK Kashyap, ... Scientific reports 10 (1), 980, 2020 | 67 | 2020 |
| An update on pharmaceutical strategies for oral delivery of therapeutic peptides and proteins in adults and pediatrics N Dan, K Samanta, H Almoazen Children 7 (12), 307, 2020 | 53 | 2020 |
| New paradigm of an old target: An update on structural biology and current progress in drug design towards plasmepsin II N Dan, S Bhakat European journal of medicinal chemistry 95, 324-348, 2015 | 27 | 2015 |
| VERU-111 suppresses tumor growth and metastatic phenotypes of cervical cancer cells through the activation of p53 signaling pathway VK Kashyap, N Dan, N Chauhan, Q Wang, S Setua, PKB Nagesh, S Malik, ... Cancer letters 470, 64-74, 2020 | 21 | 2020 |
| Application of Response Surface Methodology (RSM) in statistical optimization and pharmaceutical characterization of a matrix tablet formulation using metformin HCl as a model drug TK Pal, S Dan, N Dan Innoriginal: International Journal Of Sciences, 2014 | 14 | 2014 |
| Use of molecular dynamics simulation to explore structural facets of human prion protein with pathogenic mutations G Borgohain, N Dan, S Paul Biophysical Chemistry 213, 32-39, 2016 | 9 | 2016 |
| State of the art of silica nanoparticles: an overview on biodistribution and preclinical toxicity studies J Yu, N Dan, SM Eslami, X Lu The AAPS Journal 26 (3), 35, 2024 | 6 | 2024 |
| The updates on Middle East Respiratory Syndrome coronavirus (MERS-CoV) epidemiology, pathogenesis, viral genome and currently available drugs SS Jadav, NM Ganta, A Kumar, N Dan, NP Mohanty Journal of Pharmaceutical Chemistry 3 (2), 10-18, 2016 | 5 | 2016 |
| Impact of controlled ice nucleation on intracellular dehydration, ice formation and their implications on T cell freeze–thaw viability N Dan, S Shelake, WC Luo, M Rahman, J Lu, RH Bogner, X Lu International Journal of Pharmaceutics 665, 124694, 2024 | 2 | 2024 |
| Nanodelivery platform for targeting mutant-KRAS and improving response to gemcitabine therapy N Dan, S Khan, S Setua, S Kumari, P Chowdhury, K Samanta, M Jaggi, ... Cancer Research 79 (13_Supplement), 3625-3625, 2019 | 2 | 2019 |
| 5'Adenosine Monophosphate-Activated Protein Kinase Modulators as Anticancer Agents A Thakur, N Dan, S Bhakat, V Jayaprakash, S Banerjee Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2016 | 2 | 2016 |
| MicroRNA-145 gene therapy for pancreatic cancer using exosome as carrier source derived from cancer cells K Samanta, S Khan, S Setua, S Kumari, N Dan, MM Yallapu, M Jaggi, ... Cancer Research 79 (13_Supplement), 3564-3564, 2019 | 1 | 2019 |
| An Update on Pharmaceutical Strategies for Oral Delivery of Therapeutic Peptides and Proteins N Dan The University of Tennessee Health Science Center, 2019 | 1 | 2019 |
| Antibody mediated targeted drug delivery approach for pancreatic cancer N Dan, S Setua, P Shaji, S Kumari, MM Yallapu, SS Khan, S Chauhan Cancer Research 84 (6_Supplement), 3209-3209, 2024 | | 2024 |
| Novel strategy to make KRAS targeted therapies more effective for PDAC treatment AI Martinez Bulnes, M Elizondo, O Garcia, PD Shaji, S Holla, N Dan, ... | | 2024 |
| Antibody mediated Targeted Drug Delivery approach for Pancreatic Tumors N Dan, S Setua, M Yallapu, S Behrman, S Chauhan, S Khan | | 2024 |
| Targeted Treatment for KRAS12D For PDAC Treatment A Bulnes, O Garcia, PD Shaji, M Elizondo, S Holla, N Dan, A Dhasmana, ... | | 2024 |